Compare Charter Communications Inc (CHTR) vs TransMedics Group Inc (TMDX) Price & Performance

Charter Communications (CHTR) trades at $149.86, down 2.24% on the day, with a bullish technical signal from moving averages but bearish oscillators. The stock exhibits low valuation multiples with a P/E of 4.1 and P/S of 0.37, while profitability remains solid with a 9.05% net income margin. Recent Q2 2026 earnings beat estimates, though revenue declined year-over-year, and the company has been active in debt management, pricing $4.75 billion in senior secured notes in early August 2026.

The outlook is mixed; the low valuation presents a potential opportunity, but risks include persistent broadband subscriber losses, high debt levels, and competitive pressures. Analyst consensus leans slightly bullish with a $166.18 price target, though sentiment is cautious due to operational headwinds. The stock's trajectory hinges on reversing subscriber trends and managing leverage effectively.

TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.

Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.